Freestone Capital Holdings’s Merck MRK Stock Holding History

Freestone Capital Holdings’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.79M	Sell	81,403 -5,732	-7%	-$662K	0.3%	60
2025 Q4	$9.17M	Buy	87,135 +720	+0.8%	+$67.6K	0.27%	64
2025 Q3	$7.25M	Buy	86,415 +1,539	+2%	+$127K	0.22%	73
2025 Q2	$6.72M	Buy	84,876 +13,135	+18%	+$1.04M	0.23%	75
2025 Q1	$6.44M	Buy	71,741 +635	+0.9%	+$59.3K	0.24%	73
2024 Q4	$7.07M	Buy	71,106 +1,067	+2%	+$110K	0.24%	65
2024 Q3	$7.95M	Buy	70,039 +3,244	+5%	+$385K	0.27%	63
2024 Q2	$8.27M	Buy	66,795 +2,011	+3%	+$259K	0.3%	62
2024 Q1	$8.55M	Buy	64,784 +462	+0.7%	+$56.9K	0.32%	60
2023 Q4	$7.01M	Buy	64,322 +825	+1%	+$85.6K	0.31%	62
2023 Q3	$6.54M	Sell	63,497 -3,706	-6%	-$399K	0.35%	59
2023 Q2	$7.75M	Sell	67,203 -1,249	-2%	-$142K	0.31%	61
2023 Q1	$7.28M	Sell	68,452 -2,611	-4%	-$282K	0.32%	55
2022 Q4	$7.88M	Sell	71,063 -14,998	-17%	-$1.53M	0.36%	54
2022 Q3	$7.41M	Sell	86,061 -19,783	-19%	-$1.77M	0.33%	51
2022 Q2	$9.65M	Sell	105,844 -43,005	-29%	-$3.81M	0.37%	42
2022 Q1	$12.2M	Sell	148,849 -24,475	-14%	-$1.93M	0.49%	42
2021 Q4	$13.3M	Sell	173,324 -7,311	-4%	-$582K	0.56%	39
2021 Q3	$13.6M	Buy	180,635 +16,749	+10%	+$1.27M	0.68%	32
2021 Q2	$12.7M	Buy	163,886 +14,583	+10%	+$1.08M	0.64%	35
2021 Q1	$11M	Buy	149,303 +18,919	+15%	+$1.4M	0.6%	37
2020 Q4	$10.2M	Buy	130,384 +7,171	+6%	+$548K	0.59%	32
2020 Q3	$9.75M	Buy	123,213 +18,498	+18%	+$1.45M	0.64%	32
2020 Q2	$7.73K	Sell	104,715 -22,996	-18%	-$1.73M	0.09%	47
2020 Q1	$9.38K	Buy	127,711 +53,403	+72%	+$4.2M	0.2%	31
2019 Q4	$6.45K	Buy	74,308 +43,426	+141%	+$3.57M	0.13%	52
2019 Q3	$2.48K	Buy	30,882 +5,992	+24%	+$480K	0.06%	157
2019 Q2	$1.99K	Sell	24,890 -1,513	-6%	-$116K	0.05%	164
2019 Q1	$2.1M	Buy	26,403 +1,662	+7%	+$124K	0.12%	160
2018 Q4	$1.8M	Buy	24,741 +536	+2%	+$37.8K	0.12%	166
2018 Q3	$1.64M	Buy	24,205 +9,034	+60%	+$576K	0.01%	179
2018 Q2	$879K	Buy	15,171 +496	+3%	+$28K	0.01%	237
2018 Q1	$763K	Buy	14,675 +4,956	+51%	+$268K	0.04%	243
2017 Q4	$522K	Buy	9,719 +73	+0.8%	+$4.05K	0.04%	262
2017 Q3	$589K	Buy	9,646 +71	+0.7%	+$4.3K	0.04%	245
2017 Q2	$586K	Buy	9,575 +187	+2%	+$11.4K	0.05%	246
2017 Q1	$569K	Buy	9,388 +602	+7%	+$36.5K	0.04%	257
2016 Q4	$494K	Sell	8,786 -1,537	-15%	-$90K	0.04%	269
2016 Q3	$615K	Sell	10,323 -3,076	-23%	-$180K	0.06%	230
2016 Q2	$737K	Sell	13,399 -2,794	-17%	-$149K	0.07%	205
2016 Q1	$818K	Buy	16,193 +977	+6%	+$47.9K	0.09%	190
2015 Q4	$767K	Buy	15,216 +1,342	+10%	+$67.7K	0.08%	211
2015 Q3	$654K	Buy	+13,874	New	+$737K	0.07%	203
2014 Q1	–	Sell	-17,816	Closed	-$851K	–	272
2013 Q4	$851K	Sell	17,816 -23,526	-57%	-$1.08M	0.15%	116
2013 Q3	$1.82M	Buy	41,342 +22,346	+118%	+$1.02M	0.32%	53
2013 Q2	$842K	Buy	+18,996	New	+$848K	0.17%	98

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Freestone Capital Holdings's MRK Position: Q1 2026 in Review

Freestone Capital Holdings reduced its Merck (MRK) stake by 6.6% in Q1 2026, selling an estimated $662K and leaving 81,403 shares worth $9.79M. The position accounts for 0.3% of the portfolio, ranked #60.

Freestone Capital Holdings first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $13.6M in Q3 2021. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Freestone Capital Holdings held 81,403 shares of Merck worth $9.79M as of Q1 2026.
Freestone Capital Holdings sold 5,732 Merck shares in Q1 2026, an estimated $662K.
Merck made up 0.3% of Freestone Capital Holdings's portfolio in Q1 2026, its #60 holding.
Freestone Capital Holdings first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
Freestone Capital Holdings's Merck position peaked at $13.6M in Q3 2021.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.